Bunazosin
- Generic Name
- Bunazosin
- Drug Type
- Small Molecule
- Chemical Formula
- C19H27N5O3
- CAS Number
- 80755-51-7
- Unique Ingredient Identifier
- 9UUW4V7G2H
- Background
Bunazosin has been used in trials studying the treatment of High Blood Pressure.
Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential Hypertension
Phase 4
Completed
- Conditions
- High Blood Pressure
- Interventions
- First Posted Date
- 2005-08-15
- Last Posted Date
- 2013-05-14
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 93
- Registration Number
- NCT00130156
- Locations
- 🇨🇳
National Taiwan University Hospital., Taipei, Taiwan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath